PMC:7461420 / 68614-69134
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T268 | 382-392 | Body_part | denotes | pyrimidine | http://purl.org/sig/ont/fma/fma82773 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T323 | 69-73 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T324 | 408-412 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T830 | 204-214 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
| T831 | 234-237 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
| T832 | 264-272 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T833 | 371-372 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T834 | 440-443 | http://purl.obolibrary.org/obo/CLO_0001053 | denotes | 121 |
| T835 | 455-458 | http://purl.obolibrary.org/obo/CLO_0001053 | denotes | 121 |
| T836 | 517-520 | http://purl.obolibrary.org/obo/CLO_0054057 | denotes | 181 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T46132 | 23-28 | Chemical | denotes | furan | http://purl.obolibrary.org/obo/CHEBI_35559 |
| T10057 | 38-48 | Chemical | denotes | pyrazolone | http://purl.obolibrary.org/obo/CHEBI_83328 |
| T72340 | 98-113 | Chemical | denotes | Mpro inhibitors | http://purl.obolibrary.org/obo/CHEBI_147285 |
| T95181 | 103-113 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T23116 | 382-392 | Chemical | denotes | pyrimidine | http://purl.obolibrary.org/obo/CHEBI_16898 |
| T19786 | 419-434 | Chemical | denotes | Mpro inhibitors | http://purl.obolibrary.org/obo/CHEBI_147285 |
| T97108 | 424-434 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2140 | 419-423 | Gene | denotes | Mpro | Gene:8673700 |
| 2141 | 98-102 | Gene | denotes | Mpro | Gene:8673700 |
| 2142 | 80-84 | Gene | denotes | Mpro | Gene:8673700 |
| 2143 | 69-77 | Species | denotes | SARS‐CoV | Tax:694009 |
| 2144 | 89-97 | Species | denotes | MERS‐CoV | Tax:1335626 |
| 2145 | 408-416 | Species | denotes | SARS‐CoV | Tax:694009 |
| 2146 | 38-48 | Chemical | denotes | pyrazolone | MESH:C038362 |
| 2147 | 382-392 | Chemical | denotes | pyrimidine | MESH:C030986 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T595 | 136-215 | Sentence | denotes | 182 Compounds 115, 117, and 118 exhibited the best dual inhibitory activities. |
| T596 | 216-333 | Sentence | denotes | Compounds 115 and 116 also displayed inhibitory activity against H5N1 neuraminidase (IC50 2.8, 2.9 µM, respectively). |
| T597 | 334-445 | Sentence | denotes | 183 Ramajeyam et al. also disclosed a range of pyrimidine derivatives as SARS‐CoV‐1 Mpro inhibitors (119–121). |
| T598 | 446-516 | Sentence | denotes | Compound 121 showed high inhibitory potency with an IC50 value 6.1 µM. |
| T599 | 517-520 | Sentence | denotes | 181 |